Independent Insights, a Health Mart Podcast
Independent Insights, a Health Mart Podcast brings together independent pharmacy owners and other community pharmacy experts to inspire all pharmacy team members to not just survive, but thrive in building practices that cater to the needs of local communities. Plug in to hear ways to innovate patient care services and strengthen the overall health of your pharmacy business.
Plus, sharpen your clinical skills with GameChangers Clinical Conversations - a weekly pharmacotherapy podcast featuring the latest game-changing advances in patient care. New episodes arrive every Monday and are available for CE credit. Check the show notes for instructions on how to redeem your credit.
Happy listening!
Episodes
133 episodes
MOUD Prescribing Authority and Practice Implications
Access to medications for opioid use disorder (MOUD) remains a critical component of addressing the ongoing opioid crisis, and recent federal authorization now allows pharmacists to independently prescribe buprenorphine following appropriate tr...
Practical Updates From the New Cholesterol Guidelines
Updated cholesterol guidelines introduce important changes in cardiovascular risk assessment and lipid management that directly impact pharmacist practice. This course reviews key updates from the new ACC/AHA dyslipidemia guideline, including r...
Episode 24: Automation That Works: How Independent Pharmacies Decide, Implement, and Thrive
Join host Dr. Britney Woods, PharmD, Sr. Manager of Community Pharmacy at McKesson Health Mart, for a compelling conversation about the power of automation in independent pharmacies. This episode features special guests Faisal Adam, Pharmacist ...
Help Patients Navigate Seasonal Allergies
Seasonal allergies affect millions of patients each year and are a common reason individuals seek guidance from pharmacists for symptom relief and product selection. This course reviews the pathophysiology, common symptoms, and current manageme...
Pharmacy’s Role in HPV Self‑Screening
Federal guidelines now recognize self‑collected HPV testing as an option for cervical cancer screening for average‑risk individuals, offering a more accessible and patient‑preferred alternative to clinician‑collected samples. This cour...
Atopic Dermatitis Treatment and Guideline Updates
Treatment for atopic dermatitis has changed dramatically, with new therapies offering more targeted relief across the severity spectrum. This course highlights recent drug approvals, updated guideline recommendations, and the clinical implicati...
Hypertension Updates Every Pharmacist Should Know
Advancements in hypertension management are shifting the landscape of treatment, from new guideline recommendations to technological innovations. This course explores key highlights from the AHA's recent scientific statements, including single-...
Alpha-Gal Syndrome and the Role of the Pharmacist
Alpha-gal syndrome (AGS), a growing allergy linked to tick bites and mammalian meat exposure, is a condition pharmacists can’t afford to overlook. This course discusses the pathophysiology of the syndrome, common triggers, and emerging case tre...
Episode 23: Community Roots to Clinical Impact: Inside a Pharmacy of the Year Winner
What does it look like to build a pharmacy that not only survives—but thrives?In this episode of Independent Insights, host Britney Woods talks with Dave Randolph, owner of Dave’s Pharmacy, and Mikayla Smith, pharmacy manager, a...
How AI is Reshaping Patient Care
Artificial intelligence (AI) is rapidly transforming the healthcare landscape—and pharmacy is no exception. This course explores emerging and potential uses of AI in pharmacy practice, including workflow automation, drug information access, and...
Second-Generation Antipsychotics as Adjunctive Therapy for Depression
Second-generation (also known as atypical) antipsychotics are increasingly used as adjunctive therapy for patients with major depressive disorder who have an inadequate or partial response to antidepressants. This course reviews the clinical ra...
Recent Updates on GLP-1 Therapies
GLP‑1 receptor agonists continue to generate clinical and media buzz, with new formulations, new approvals, and expanding areas of research. This course explores key updates, including the FDA approval of the first oral GLP‑1 for chronic weight...
Shared Clinical Decision-Making and the Pharmacist’s Role
Recent changes to childhood vaccine recommendations have introduced shared clinical decision‑making for several immunizations that were previously universally recommended, creating confusion among patients and providers alike. This course expla...
Episode 22: Top 10 Reasons to Press Play
A familiar format, a subtle shift, and something worth sticking around for. This episode includes an introduction to the next chapter of Independent Insights. HostSuzanne Feeney, PharmDSr. Director, Pharmacy Solution...
Balancing the Benefits and Risks of Gabapentin
As gabapentin climbs the ranks to become one of the most prescribed medications in the U.S., questions about its safety and scope of use are also rising. This episode explores recent trends in gabapentin use, highlights key patient safety conce...
Updates in HIV PEP Protocols and Guidelines
Recent updates to U.S. guidelines for HIV post‑exposure prophylaxis (PEP) provide modernized recommendations for both non‑occupational and occupational exposures — reflecting advances in antiretroviral therapy and evolving evidence. This course...
Updates in HIV PrEP Therapy Options
Recent developments in HIV prevention — including the FDA approval of a 6‑month injectable option and updated clinical guidance — are changing the landscape of Pre-Exposure Prophylaxis (PrEP) therapy. This course reviews the latest developments...
The Role of Biosimilars in Managing Inflammatory Disease
With the number of biosimilar products steadily increasing, pharmacists play a central role in ensuring their appropriate use in inflammatory conditions. This episode highlights approval pathways, interchangeability, and real-world challenges p...
Episode 21: Inside NIAB – Shaping the Future of Independent Pharmacy
Join us for a special live episode of Independent Insights as we sit down with members of the National Independent Advisory Board (NIAB), at McKesson ideaShare, to explore their vision for the future of pharmacy. Hear firsthand what th...
FDA Removes Boxed Warnings on Menopausal Hormone Therapy
Menopausal hormone therapy has long carried a boxed warning (formerly a "black box warning") that may not accurately reflect the therapy's risk-benefit profile for all patients. This course discusses the FDA's recent removal of boxed warnings f...
Key Updates on the Return of Ranitidine
Ranitidine — once withdrawn from the market over safety concerns — was recently re‑approved by the FDA in a reformulated version, raising important questions for pharmacists and patients alike. This course outlines the FDA’s recent approval, re...
Measles And Whooping Cough Resurge
Recent years have seen a troubling resurgence of whooping cough and measles — diseases many thought were largely controlled — highlighting the continuing importance of vaccination, surveillance, and community education. This course reviews the ...
The Great Debate of Steroid Use in CAP
Corticosteroids in the treatment of community-acquired pneumonia (CAP) remain a topic of clinical curiosity and mixed opinions. In this unique episode, two expert guests share opposing perspectives—one advocating for corticosteroid use in CAP a...
Episode 20: Provider-Ready Now- Residency & Credentialing for Independent Growth
In this episode, host Suzanne Feeney, PharmD, Senior Director, Pharmacy Solutions at McKesson Health Mart and guest Jaime Montuoro, PharmD, Director of Education & Practice Advancement at McKesson Health Mart, unpack two strategies you can ...
The Truth About Cannabis and Pregnancy Outcomes
As cannabis becomes more widely available and socially accepted, so does the misconception that it's safe to use during pregnancy and lactation. This course reviews updated guidance from the American College of Obstetricians and Gynecologists (...
